FROM OUR BLOG

Nvidia Crisis Rocks Markets; Surgery Partners Bid Hits $6B

Nvidia's CEO scandal hammers tech stocks, while HealthSpan Partners ups its Surgery Partners bid to $6B in a heated acquisition battle.

November 12, 2026

This week in brief

  • Healthcare Practice & Business Deals: This week’s sharpest healthcare deal news centers on a contested surgical network acquisition and a major digital-health platform buy.
  • Global Markets & Macro: Global markets face a turbulent week, with the Nvidia leadership crisis dominating sentiment and geopolitical flashpoints adding further pressure.

Healthcare Practice & Business Deals

This week’s sharpest healthcare deal news centers on a contested surgical network acquisition and a major digital-health platform buy.

HealthSpan Partners Raises Surgery Partners Bid to $6B. Bon Secours’ affiliate HealthSpan Partners has lifted its offer for Surgery Partners to $6 billion — a $300 million increase over its prior proposal. The move comes directly in response to a rival bid for the extensive surgical care network. Competition for Surgery Partners is now open and intensifying, with two parties pushing valuations higher in real time.

Oura Acquires AI Virtual Primary Care Firm Counsel Health for $625M. Wearable technology company Oura has agreed to acquire Counsel Health, an AI-powered virtual primary care partner, for $625 million. The two companies had worked together since June and had recently announced plans to collaborate on the CMS ACCESS Model. The deal signals a broader push by wearable firms to deepen their healthcare delivery capabilities.

BJC Health and St. Luke’s Plan to Merge. BJC Health and St. Luke’s have signed a letter of intent to merge, bringing St. Luke’s community hospital into BJC’s network — Missouri’s largest health system. The parties have not disclosed financial terms. While this is a health-system combination rather than a small-practice deal, the transaction is notable for its direct impact on community hospital access in the region.

Global Markets & Macro

Global markets face a turbulent week, with the Nvidia leadership crisis dominating sentiment and geopolitical flashpoints adding further pressure.

Nvidia CEO Crisis Halts Tech Rally. Nvidia’s board is actively meeting to consider the future of Chief Executive Officer Jensen Huang, following reports of multiple extramarital affairs — including one involving a woman suspected of spying for China. Nvidia shares fell as much as 8.4% in premarket trading on the news. At those levels, the stock’s market capitalization would drop below $4 trillion. The Nasdaq 100 also pulled back sharply, threatening to erase the index’s best weekly gain since May. Long-dated US Treasuries rose as investors sought safer assets amid the turmoil.

China Accuses US of Fabricating Espionage Narrative. Beijing pushed back against the Nvidia controversy, accusing the United States of fabricating “espionage narratives” and warning Washington not to use the scandal as a pretext for new technology export restrictions. The statement adds a geopolitical dimension to what began as a corporate governance story and raises the stakes for the broader US-China tech rivalry.

Ukraine Strikes Russia’s Largest Oil Refinery — Again. Ukraine said it attacked Russia’s biggest oil refinery in western Siberia for a third time, escalating its campaign against Russian crude-processing infrastructure. Meanwhile, Russian diesel exports reportedly doubled after sanctions relief, though analysts expect that boost to be short-lived as Ukraine presses its refinery campaign. US-mediated peace talks between the two sides are ongoing, with American envoys traveling to Moscow.

UK Economy Grows 0.7% in Q3. The United Kingdom’s economy expanded by 0.7% in the third quarter, according to official figures. The result underscores resilience despite surging energy prices and rising borrowing costs. However, the ongoing energy crisis continues to weigh on households and businesses alike.

Partisan Sentiment Swings Sharply After Midterms. Consumer sentiment shifted along party lines in the days following the US midterm elections, according to Morning Consult data shared with Axios. Democratic sentiment rose 6.5 points in the five days after the vote, while Republican sentiment fell 6.4 points. Overall sentiment barely moved, as the opposing shifts largely canceled each other out. Analysts note that consumer sentiment increasingly reflects political identity rather than actual spending behavior.

What to Watch

The week ahead turns on two fault lines. In healthcare, the contested Surgery Partners acquisition is live — a higher rival bid could force HealthSpan Partners to respond again, and the outcome will set a valuation benchmark for large surgical networks entering private-equity hands. In markets, all eyes remain on Nvidia’s board and any succession announcement, which could either restore confidence in the AI supply chain or extend the technology selloff. Add to that the fragile US-Russia diplomatic track and persistent questions about UK and global growth, and both deal-makers and investors have plenty to monitor before Friday’s close.


Editorial note, image use & corrections. This report is compiled and summarized from publicly available news sources; figures and details should be independently verified. Accompanying images are used under Creative Commons or public-domain licenses (sourced via Openverse) and credited where required. If you believe any content — written or image — has been used in error, is inaccurate, or infringes your rights, or you wish to request a correction or removal, please contact us at info@tenetma.com and we will address it promptly.

What do these market moves mean for your practice value?

Get a confidential read on what your practice is worth in today's market.

Request a confidential review

About Tenet Mergers & Acquisitions

Tenet Mergers & Acquisitions is a sell-side advisory firm for healthcare practice owners exploring a sale, partnership or transition.

Meet the team

THINKING ABOUT SELLING YOUR MEDICAL PRACTICE?

Get a confidential practice valuation.

If you’re considering selling your practice — or exploring your options — a confidential valuation is a helpful first step. Understanding market conditions and potential value provides clarity and supports better decisions around timing and strategy.

START THE CONVERSATION

If you’re considering a sale, exploring acquisitions or planning ahead,
we’re here to help.

Schedule a confidential consultation to learn how our services can support your goals.